Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 74853-08-0 | MDL No. : | MFCD02093082 |
Formula : | C16H19N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WZIJMPVPOMTRNM-UHFFFAOYSA-N |
M.W : | 269.34 | Pubchem ID : | 10221065 |
Synonyms : |
|
Num. heavy atoms : | 20 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 89.37 |
TPSA : | 52.73 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.1 cm/s |
Log Po/w (iLOGP) : | 1.93 |
Log Po/w (XLOGP3) : | 2.6 |
Log Po/w (WLOGP) : | 1.55 |
Log Po/w (MLOGP) : | 1.87 |
Log Po/w (SILICOS-IT) : | 1.35 |
Consensus Log Po/w : | 1.86 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.46 |
Solubility : | 0.0934 mg/ml ; 0.000347 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.36 |
Solubility : | 0.119 mg/ml ; 0.00044 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.76 |
Solubility : | 0.0465 mg/ml ; 0.000173 mol/l |
Class : | Soluble |
PAINS : | 2.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.79 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With sodium hypophosphite In 2-methoxy-ethanol; water at 70 - 80℃; for 2 - 2.5 h; | Under nitrogen, 430 g (1.34 mol) N-(4-Hydroxyphenyl)-N'-(4'-nitrophenyl)-piperazine are suspended in 2.8 liters methoxyethanol at 20° - 25° C. After the addition of 52 g palladium ((5percent on charcoal, 50percent water wet) (Degussa Typ E1049)) the suspension is degassed (3 times) and heated to 70° - 75° C. A solution of 497 g sodium hypophosphite monohydrate in 1.12 liters water is slowly added over 2 -2.5 hours at 70° - 75° C. (After addition of about 10 ml the evolution of hydrogenation starts and the temperature has to be kept at 75° - 80° C; towards the end of the addition external heating is needed). After complete addition, the reaction mixture is stirred at 70° - 75° C and the reaction is followed by TLC (silicagel, n-hexane/ethylacetate 1/2). After complete conversion (30 - 45 minutes, color turns from brown-yellow to grey) the suspension is cooled to 25° - 30° C and diluted with 2.4 liters water. The pH is adjusted to <=2 by the addition of about 400 ml concentrated HCl (about 10 minutes) at 25° to 30° C and stirred at this temperature for about 15 minutes. The catalyst is filtered off and washed with 600 ml water. The combined filtrates are warmed to 35° to 40° C and the pH is adjusted to 7.1 +/- 1 at 35° to 40° C by the addition of about 760 ml concentrated sodium hydroxide (slightly exothermic). The resulting suspension is cooled to 20° - 25° C and stirred at that temperature for 30 minutes. The product is filtered off under nitrogen (about 40 minutes) and washed twice with 1.6 liters water, followed by 400 ml water/methanol (1:1) and 800 ml methanol. The product is dried under vacuum at 50° C (slight stream of nitrogen) to constant weight. [] Yield317 g (88percent)Assay (HPLC)99.7percent pure by area |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94.6% | at 0 - 25℃; Large scale | Will be 4.00kg1- (4-aminophenyl) -4- (4-hydroxyphenyl) piperazine (VII) and 35.57 kg of tetrahydrofuran100L glass reactor, open the stirring, cooling to 0 ~ 10 .Maintain the temperature below 25 drop 2.56kgPhenyl chloroformate (VIII),0.5 to 1 hour drop finished, temperature control 20 ~ 25 to continue the reaction of 0.5 to 1.0 hours. TLC monitoring reaction, the reaction finishedAfter the completion of the cooling to 0 ~ 10 ,Add saturated aqueous sodium bicarbonate solution (sodium bicarbonate 2.00kg dissolved in purified water 38kg), then add purified water 20kg,Stirring for 10 ~ 20min. Centrifuge the filter to the basic solvent-free effluent, and then rinse with 8kg of purified water, centrifugal rejection to the basic solvent-free effluent.The whole batch of wet goods in the vacuum -0.06MPa ~ -0.1MPa, the control temperature of 40-50 conditions,Dry under reduced pressure 12 to 16 hours. 5.47 kg of a gray solid,Phenyl (4- (4- (4-hydroxy) -1-piperazinyl) phenyl) carbamate(V);HPLC purity: 98.5percent yield: 94.6percent |
215 g | at 0 - 30℃; for 3 h; | Example-8 Preparation of Phenyl-4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl carbamate (Formula-19) Phenyl chloroformate (139.5 g) was added to a pre-cooled solution of 4-(4-(4-aminophenyl)piperazin-1-yl)phenol compound of formula-18 (200 g) in dimethyl formamide (1400 ml) at 0-10° C. Temperature of the reaction mixture was raised to 25-30° C. and then stirred for 3 hours at 25-30° C. After completion of the reaction, the reaction mixture was quenched with water. Filtered the precipitated solid and washed with water. |
[ 184177-81-9 ]
Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate
[ 5882-48-4 ]
4-(Dimethylamino)phenol hydrochloride
Similarity: 0.86
[ 5882-48-4 ]
4-(Dimethylamino)phenol hydrochloride
Similarity: 0.86
[ 122833-04-9 ]
2-Methoxy-4-(4-methylpiperazin-1-yl)aniline
Similarity: 0.82
[ 5521-39-1 ]
2-(4-(4-Aminophenyl)piperazin-1-yl)ethanol
Similarity: 0.77
[ 112559-81-6 ]
4-(4-(4-Nitrophenyl)-1-piperazinyl)phenol
Similarity: 0.76
[ 16153-81-4 ]
4-(4-Methylpiperazin-1-yl)phenylamine
Similarity: 0.74
[ 122833-04-9 ]
2-Methoxy-4-(4-methylpiperazin-1-yl)aniline
Similarity: 0.82
[ 5521-39-1 ]
2-(4-(4-Aminophenyl)piperazin-1-yl)ethanol
Similarity: 0.77
[ 112559-81-6 ]
4-(4-(4-Nitrophenyl)-1-piperazinyl)phenol
Similarity: 0.76
[ 89026-59-5 ]
4-(4-Methoxyphenyl)piperazine-1-carboxamide
Similarity: 0.75